These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5915776)

  • 1. The availability of antibiotics in combination with other additives in intravenous solutions.
    Dancey JW; Carew DP
    Am J Hosp Pharm; 1966 Oct; 23(10):543-51. PubMed ID: 5915776
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous versus intermittent intravenous antibiotics.
    Med Lett Drugs Ther; 1968 Jul; 10(15):57-8. PubMed ID: 5667663
    [No Abstract]   [Full Text] [Related]  

  • 3. A pH pattern for I.V. additives.
    Webb JW
    Am J Hosp Pharm; 1969 Jan; 26(1):31-5. PubMed ID: 5763886
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous admixture incompatibility information program.
    Donn R
    Bull Parenter Drug Assoc; 1970; 24(2):98-103. PubMed ID: 5439919
    [No Abstract]   [Full Text] [Related]  

  • 5. Problems of intravenous additives.
    Ryan F
    RANF Rev; 1977 Jan; 8(1):1, 3. PubMed ID: 585112
    [No Abstract]   [Full Text] [Related]  

  • 6. [Incompatibilities of antibiotics administered by venous infusion].
    Flouvat B; Lechat P
    Therapie; 1974; 29(3):337-56. PubMed ID: 4439354
    [No Abstract]   [Full Text] [Related]  

  • 7. Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection.
    Nieves-Cordero AL; Luciw HM; Souney PF
    Am J Hosp Pharm; 1985 May; 42(5):1108-9. PubMed ID: 4003421
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacy of ceftazidime.
    Richardson BL; Woodford JD; Andrews GD
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():233-6. PubMed ID: 19802991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extemporaneous sterile compounding of intravenous additives.
    Meisler JM; Skolaut MW
    Am J Hosp Pharm; 1966 Oct; 23(10):557-63. PubMed ID: 5953067
    [No Abstract]   [Full Text] [Related]  

  • 10. pH--an important factor in the compatibility of additives in intravenous therapy.
    Mary Edward Sister
    Am J Hosp Pharm; 1967 Aug; 24(8):440-9. PubMed ID: 6075729
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous admixture training program for pharmacy personnel.
    Hunt ML
    Am J Hosp Pharm; 1974 May; 31(5):467-71. PubMed ID: 4829388
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous drug incompatibilities.
    Morris ME
    Am J Nurs; 1979 Jul; 79(7):1288-91. PubMed ID: 36757
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic availability of antibiotics in parenteral solutions.
    Bair JN; Carew DP
    Bull Parenter Drug Assoc; 1965; 19(6):153-63. PubMed ID: 5837809
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thin-layer chromatographic studies of injetable solutions in different combinations].
    Ito S
    Iryo; 1968 Jul; 22(7):846-52. PubMed ID: 5702016
    [No Abstract]   [Full Text] [Related]  

  • 15. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Part 2.
    Allen LV; Stiles ML
    Am J Hosp Pharm; 1981 Mar; 38(3):380-1. PubMed ID: 7223755
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug incompatibility from the standpoint of the intravenous route of drug administration.
    Williams JT
    Hosp Manage; 1968 Jan; 105(1):38 passim. PubMed ID: 5634868
    [No Abstract]   [Full Text] [Related]  

  • 17. Bacterial endophthalmitis: culture proven failure of combined systemic, periocular, and topical antibiotics.
    Mirate DJ; Hull DS; Bobo C
    Ann Ophthalmol; 1981 Dec; 13(12):1341-2. PubMed ID: 7337342
    [No Abstract]   [Full Text] [Related]  

  • 18. Compatibility considerations in parenteral nutrient solutions.
    Niemiec PW; Vanderveen TW
    Am J Hosp Pharm; 1984 May; 41(5):893-911. PubMed ID: 6328980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemical changes due to the compounding of parenteral injections. (1)].
    Kosugi T
    Iryo; 1967 Aug; 21(8):960-1. PubMed ID: 5582998
    [No Abstract]   [Full Text] [Related]  

  • 20. [Control of the quality of antibiotics and their i/v mixtures in large volume solutions].
    Giráldez J; Honorato J; Martí Massó R; Sánchez O; Fos D; Velasco J
    Rev Med Univ Navarra; 1976; 20():215-6. PubMed ID: 1019514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.